Hydroxychloroquine ameliorates immune functionality and intestinal flora disorders of IgA nephropathy by inhibition of C1GALT1/Cosmc pathway

References

• Coppo R. Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients. J Nephrol. 2017;30(3):339–346. doi: 10.1007/s40620-016-0360-z.
   PubMed Web of Science ®Google Scholar
• Qin W, Zhou Q, Yang LC, et al. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin a nephropathy. J Intern Med. 2005;258(5):467–477. doi: 10.1111/j.1365-2796.2005.01558.x.
   PubMed Web of Science ®Google Scholar
• Nam KH, Joo YS, Lee C, et al. Predictive value of mesangial C3 and C4d deposition in IgA nephropathy. Clin Immunol. 2020; 211:108331. doi: 10.1016/j.clim.2019.108331.
   PubMed Web of Science ®Google Scholar
• Yeo SC, Cheung CK, Barratt J. New insights into the pathogenesis of IgA nephropathy. Pediatr Nephrol. 2018;33(5):763–777. doi: 10.1007/s00467-017-3699-z.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang XZ, Li YS, et al. Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway. FEBS Open Bio. 2017;7(1):54–63. doi: 10.1002/2211-5463.12161.
   PubMed Web of Science ®Google Scholar
• Hu Q, Jiang L, Yan Q, et al. A natural products solution to diabetic nephropathy therapy. Pharmacol Ther. 2022;241:108314. doi: 10.1016/j.pharmthera.2022.108314.
   PubMed Web of Science ®Google Scholar
• Shahin DH, Sultana R, Farooq J, et al. Insights into the uses of traditional plants for diabetes nephropathy: a review. Curr Issues Mol Biol. 2022;44(7):2887–2902. doi: 10.3390/cimb44070199.
   PubMed Web of Science ®Google Scholar
• Seikrit C, Stamellou E, Rauen T, et al. TESTING the effects of corticosteroids in patients with IgA nephropathy. Nephrol Dial Transplant. 2022;37(10):1786–1788. doi: 10.1093/ndt/gfac221.
   Google Scholar
• Novak J, Rizk D, Takahashi K, et al. New insights into the pathogenesis of IgA nephropathy. Kidney Dis (Basel). 2015;1(1):8–18. doi: 10.1159/000382134.
   PubMed Web of Science ®Google Scholar
• Tan M, Li W, Zou G, et al. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria. Kidney Blood Press Res. 2015;40(2):200–206. doi: 10.1159/000368495.
   PubMed Web of Science ®Google Scholar
• Le W, Liang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a chinese adult population. Nephrol Dial Transplant. 2012;27(4):1479–1485. doi: 10.1093/ndt/gfr527.
   PubMed Web of Science ®Google Scholar
• Thompson A, Carroll K, Inker LA, et al. Proteinuria reduction as a surrogate end point in trials of IgA nephropathy. Clin J Am Soc Nephrol. 2019;14(3):469–481. doi: 10.2215/CJN.08600718.
   PubMed Web of Science ®Google Scholar
• Olsen NJ, Schleich MA, Karp DR editors. Multifaceted effects of hydroxychloroquine in human disease. Semin Arthritis Rheum. 2013;43(2):264–272. doi: 10.1016/j.semarthrit.2013.01.001.
   Google Scholar
• Liu L-J, Yang Y-Z, Shi S-F, et al. Effects of hydroxychloroquine on proteinuria in IgA nephropathy: a randomized controlled trial. Am J Kidney Dis. 2019;74(1):15–22. doi: 10.1053/j.ajkd.2019.01.026.
   PubMed Web of Science ®Google Scholar
• Tang C, Lv JC, Shi SF, et al. Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience. J Nephrol. 2022;35(2):429–440. doi: 10.1007/s40620-021-00988-1.
   PubMed Web of Science ®Google Scholar
• Xie L, Wang L, Huang J, et al. IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew. Sheng wu yi Xue Gong Cheng Xue za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 2010;27(1):227–230.
   PubMedGoogle Scholar
• Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–2414. doi: 10.1056/NEJMra1206793.
   PubMed Web of Science ®Google Scholar
• Buck KS, Smith AC, Molyneux K, et al. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int. 2008;73(10):1128–1136. doi: 10.1038/sj.ki.5002748.
   PubMed Web of Science ®Google Scholar
• Zhou N, Shen Y. Progression in the mechanism of the cosmc in IgA nephropathy. Zhonghua Er Ke Za Zhi. 2013;51(7):549–551.
   PubMedGoogle Scholar
• Bolscher JG, Brevoord J, Nazmi K, et al. Solid-phase synthesis of a pentavalent GalNAc-containing glycopeptide (Tn antigen) representing the nephropathy-associated IgA hinge region. Carbohydr Res. 2010;345(14):1998–2003. doi: 10.1016/j.carres.2010.07.022.
   PubMed Web of Science ®Google Scholar
• Maiguma M, Suzuki Y, Suzuki H, et al. Dietary zinc is a key environmental modifier in the progression of IgA nephropathy. PLoS One. 2014;9(2):e90558. doi: 10.1371/journal.pone.0090558.
   PubMed Web of Science ®Google Scholar
• Lu H, Chen LL, Jiang XY, et al. Temporal and spatial expression of podocyte-associated molecules are accompanied by proteinuria in IgA nephropathy rat model. Physiol Res. 2013;62(1):35–45. doi: 10.33549/physiolres.932380.
   PubMed Web of Science ®Google Scholar
• Sheng-Nan P, Hui-Hong Z, Ai-Xiang F, et al. Protection of rhein on IgA nephropathy mediated by inhibition of fibronectin expression in rats. Indian J Pharmacol. 2013;45(2):174–179. doi: 10.4103/0253-7613.108309.
   PubMed Web of Science ®Google Scholar
• Jin YH, Min JS, Kwon S. Cardamonin as a p38 MAPK signaling pathway activator inhibits human coronavirus OC43 infection in human lung cells. Nutrients. 2023;15(6):1335. doi: 10.3390/nu15061335.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang X, Lu S, et al. Metabolic disturbance and Th17/treg imbalance are associated with progression of gingivitis. Front Immunol. 2021;12:670178. doi: 10.3389/fimmu.2021.670178.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Li Y, Xia M, Peng L, et al. Downregulation of miR‑214-3p attenuates mesangial hypercellularity by targeting PTEN‑mediated JNK/c-Jun signaling in IgA nephropathy. Int J Biol Sci. 2021;17(13):3343–3355. doi: 10.7150/ijbs.61274.
   PubMed Web of Science ®Google Scholar
• Stefan G, Mircescu G. Hydroxychloroquine in IgA nephropathy: a systematic review. Ren Fail. 2021;43(1):1520–1527. doi: 10.1080/0886022X.2021.2000875.
   PubMed Web of Science ®Google Scholar
• Huang H, Peng Y, Long X-D, et al. Tonsillar CD4+ CD25+ regulatory T cells from IgA nephropathy patients have decreased immunosuppressive activity in experimental IgA nephropathy rats. Am J Nephrol. 2013;37(5):472–480. doi: 10.1159/000350533.
   PubMed Web of Science ®Google Scholar
• Ye M, Peng Y, Liu C, et al. Vibration induces BAFF overexpression and aberrant O-glycosylation of IgA1 in cultured human tonsillar mononuclear cells in IgA nephropathy. Biomed Res Int. 2016;2016:9125960–9125968. doi: 10.1155/2016/9125960.
   PubMed Web of Science ®Google Scholar
• Leffler J, Trend S, Ward NC, et al. Circulating memory B cells in early multiple sclerosis exhibit increased IgA(+) cells, globally decreased BAFF-R expression and an EBV-Related IgM(+) cell signature. Front Immunol. 2022;13:812317. doi: 10.3389/fimmu.2022.812317.
   PubMed Web of Science ®Google Scholar
• Pers JO, Daridon C, Devauchelle V, et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005;1050(1):34–39. doi: 10.1196/annals.1313.004.
   PubMedGoogle Scholar
• Xin G, Shi W, Xu L-X, et al. Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. J Nephrol. 2013;26(4):683–690. doi: 10.5301/jn.5000218.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kiryluk K, Novak J, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22(10):1795–1803. doi: 10.1681/ASN.2011050464.
   PubMed Web of Science ®Google Scholar
• Peng SN, Zeng HH, Fu AX, et al. Effects of rhein on intestinal epithelial tight junction in IgA nephropathy. World J Gastroenterol. 2013;19(26):4137–4145. doi: 10.3748/wjg.v19.i26.4137.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhu Y, He H, et al. Gut dysbiosis and intestinal barrier dysfunction promotes IgA nephropathy by increasing the production of Gd-IgA1. Front Med (Lausanne). 2022;9:944027. doi: 10.3389/fmed.2022.944027.
   PubMed Web of Science ®Google Scholar
• Noth R, Lange-Grumfeld J, Stüber E, et al. Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model. BMC Gastroenterol. 2011;11(1):109. doi: 10.1186/1471-230X-11-109.
   PubMed Web of Science ®Google Scholar
• Tash BR, Bewley MC, Russo M, et al. The occludin and ZO-1 complex, defined by small angle X-ray scattering and NMR, has implications for modulating tight junction permeability. Proc Natl Acad Sci USA. 2012;109(27):10855–10860. doi: 10.1073/pnas.1121390109.
   PubMed Web of Science ®Google Scholar
• Kiryluk K, Li Y, Scolari F, et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014;46(11):1187–1196. doi: 10.1038/ng.3118.
   PubMed Web of Science ®Google Scholar
• Pohjonen J, Nurmi R, Metso M, et al. Inflammatory bowel disease in patients undergoing renal biopsies. Clin Kidney J. 2019;12(5):645–651. doi: 10.1093/ckj/sfz004.
   PubMed Web of Science ®Google Scholar
• Zhao L, Lan Z, Peng L, et al. Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway. Cell Prolif. 2022; Sep55(9):e13278. doi: 10.1111/cpr.13278.
   PubMed Web of Science ®Google Scholar
• Perez-Muñoz ME, Bergstrom K, Peng V, et al. Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis. Gut Microbes. 2014;5(3):286–295. doi: 10.4161/gmic.28622.
   PubMed Web of Science ®Google Scholar